3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
7
Rectal Neoplasms
7
Oropharyngeal Neoplasms
7
Head and Neck Neoplasms
6
Carcinoma, Non-Small-Cell Lung
5
Pancreatic Neoplasms
3
Lung Neoplasms
3
Hypopharyngeal Neoplasms
3
Glioblastoma
3
Esophageal Neoplasms
3
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Radiation Injuries
2
Pathologic Complete Response
2
Nasopharyngeal Carcinoma
2
Mouth Neoplasms
2
Laryngeal Neoplasms
2
Vaginal Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Tobacco Use Disorder
1
Thymoma
1
Smoking Cessation
1
Smoking
1
Small Cell Lung Carcinoma
1
Sinonasal undifferentiated carcinoma
1
Sinonasal Squamous Cell Carcinoma
1
Resectable Esophageal Cancer
1
Rectal Malignant Neoplasms
1
Postoperative Complications
1
Interventions
Bevacizumab
5
Cetuximab
3
palbociclib
2
encorafenib
2
Leucovorin
2
Irinotecan
2
Fluorouracil
2
tislelizumab
1
ribociclib
1
repotrectinib
1
olaparib
1
fludarabine
1
durvalumab
1
dostarlimab
1
atezolizumab
1
Tretinoin
1
Stem Cell Transplantation
1
Sirolimus
1
Ramucirumab
1
Radiotherapy
1
Paclitaxel
1
Oxaliplatin
1
Oviposition
1
Melphalan
1
Lutetium-177
1
Lutetium
1
Levoleucovorin
1
Injections
1
Immunotherapy
1
Imatinib Mesylate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Digestive System Neoplasms
×
Chemoradiotherapy
×
1 year
×
Clear all
No trials found.